Warning! GuruFocus detected
6 Severe warning signs
with A2T.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Atrys Health SA
ISIN : ES0105148003
Compare
Compare
Traded in other countries / regions
ATRY.SpainA2T.GermanyATRYe.UK IPO Date
2021-05-04Description
Atrys Health SA is a Spain based biomedical company which focuses on developing tools for the diagnosis and treatment of cancer and precancerous conditions. It offers diagnostic services in the fields of pathology, hematology, molecular pathology, and genetics. The company uses telemedicine to provide its services in the medical specialties of radiology, cardiology, ophthalmology, and dermatology.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.08 | |||||
| Equity-to-Asset | 0.43 | |||||
| Debt-to-Equity | 1.01 | |||||
| Debt-to-EBITDA | 13.4 | |||||
| Interest Coverage | 0.4 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 0.61 | |||||
| Beneish M-Score | -2.65 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 4.7 | |||||
| 3-Year EBITDA Growth Rate | 21.5 | |||||
| 3-Year EPS without NRI Growth Rate | 24.4 | |||||
| 3-Year FCF Growth Rate | -19.9 | |||||
| 3-Year Book Growth Rate | -9.1 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 7.55 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 16.61 | |||||
| 9-Day RSI | 27.25 | |||||
| 14-Day RSI | 32.31 | |||||
| 3-1 Month Momentum % | -2.42 | |||||
| 6-1 Month Momentum % | 1.25 | |||||
| 12-1 Month Momentum % | 9.86 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.89 | |||||
| Quick Ratio | 0.88 | |||||
| Cash Ratio | 0.21 | |||||
| Days Inventory | 8.71 | |||||
| Days Sales Outstanding | 89.08 | |||||
| Days Payable | 108.09 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -7.4 | |||||
| Shareholder Yield % | 1.56 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 68.34 | |||||
| Operating Margin % | 4.36 | |||||
| Net Margin % | -14.94 | |||||
| FCF Margin % | -4.77 | |||||
| ROE % | -11.71 | |||||
| ROA % | -5.25 | |||||
| ROIC % | 1.52 | |||||
| 3-Year ROIIC % | 38.32 | |||||
| ROC (Joel Greenblatt) % | -11.51 | |||||
| ROCE % | -1.97 | |||||
| Years of Profitability over Past 10-Year | 3 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 91.67 | |||||
| PS Ratio | 1.05 | |||||
| PB Ratio | 0.88 | |||||
| Price-to-Operating-Cash-Flow | 77.37 | |||||
| EV-to-EBIT | -45.91 | |||||
| EV-to-EBITDA | 24.04 | |||||
| EV-to-Revenue | 2.15 | |||||
| EV-to-FCF | -45.19 | |||||
| Price-to-GF-Value | 0.49 | |||||
| Price-to-Projected-FCF | 3.82 | |||||
| Earnings Yield (Greenblatt) % | -2.18 | |||||
| FCF Yield % | -4.54 | |||||
| Forward Rate of Return (Yacktman) % | 13.74 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Atrys Health SA Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 212.743 | ||
| EPS (TTM) (€) | -0.417 | ||
| Beta | 0.69 | ||
| 3-Year Sharpe Ratio | -1.02 | ||
| 3-Year Sortino Ratio | -1.43 | ||
| Volatility % | 50.33 | ||
| 14-Day RSI | 32.31 | ||
| 14-Day ATR (€) | 0.266086 | ||
| 20-Day SMA (€) | 2.9585 | ||
| 12-1 Month Momentum % | 9.86 | ||
| 52-Week Range (€) | 2.45 - 4.14 | ||
| Shares Outstanding (Mil) | 75.92 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Atrys Health SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Atrys Health SA Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Atrys Health SA Frequently Asked Questions
What is Atrys Health SA(FRA:A2T)'s stock price today?
The current price of FRA:A2T is €2.75. The 52 week high of FRA:A2T is €4.14 and 52 week low is €2.45.
When is next earnings date of Atrys Health SA(FRA:A2T)?
The next earnings date of Atrys Health SA(FRA:A2T) is 2025-07-31 Est..
Does Atrys Health SA(FRA:A2T) pay dividends? If so, how much?
Atrys Health SA(FRA:A2T) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers